首页> 外国专利> Inhibitors of Serine proteases with lower molecular weight and polihidroxicicloalquilo polihidroxialquilo radical

Inhibitors of Serine proteases with lower molecular weight and polihidroxicicloalquilo polihidroxialquilo radical

机译:分子量较低的丝氨酸蛋白酶抑制剂和polihidroxicicloalquilo polihidroxialquilo自由基

摘要

A compound of amitriptyline or guardipine, having a general formula of a-b-d-e-g-k-l, wherein a is h, CH3, H - (ra1) ia, wherein ra1 is equal to formula (1) of a group,Among them, ra2 is h, NH2, nh-coch3, F, nhcho; RA3 is h, CH2OH; RA4 is h, CH3, COOH; IA = 1-20; JA = 0, 1, 2; Ka = 2, 3; La = 0, 1; Ma = 0, 1, 2; if ra1 excimer is greater than 1, it may be the same or different; B is a formula of this group (2);A-B is one of the group's formulas (3);Or a radical neuron acid of n-acetyl-n-acrylic acid, each of which is combined by anthrax function; RB1 is equivalent to h, CH2OH, C1-4 tar; Rb2 is equivalent to h, NH2, nh-coch3, F, nhcho; RB3 is equivalent to h, C1-4 tar, ch2-o-4, COOH, F, nh-coch3, CONH2; RB4 is equivalent to c1h, C14 tar, Ch2-o-tar C1-4, COOH, CHO, in the latter case, the intramolecular aceous may be formed; RB5 is equal to h, C1-4 tar, ch2-o-4, COH; KB = 0, 1; LB = 0, 1; LB = 0, 1, 2, 3 (Lb1 is different from 0, where a = RB1 = RB3 = h, MB = KB = 0, D is the link);MB = 0, 1, 2, 3, 4; Nb = 0, 1, 2, 3; rb6 equals C1-4 tar, phenyl, phenylethyl; BB7 equals h, C1-4 tar, benzene, phenylethyl; D equals o-n (RD1) - rd2-rd3-rd4.In the case of RD1 equal to h, C1-4 leased land; RD2 equal to C1-4 linked or leased land; RD3 equal to the formula of a group (4),LD = 1, 2, 3, 4, 5, 6 and rd5 are equal to h, C1-4 hydrocarbon, CL; rd6 is equal to h, CH3; in this case, additional aromatic or aromatic rings can be incorporated into the above RD3 ring system; RD4 is equal to link, C1-4 hydrocarbon, Co, SO2, ch2-co; E is a set of formulas (5),Among them, Ke = 0, 1, 2; E = 0, 1, 2; me = 0, 1, 2, 3; ne = 0, 1, 2; PE = 0, 1, 2; RE1 is h, C1-6 asphalt, cyclo-8, arilo (especially phenyl or naftil),Heteromorphic (especially pyridylene, butadiene, pyridylene, indolilo),e. Other RE1 as defined in the memory, in addition, re4oco-ch2 - (RE4 is equal to h, No. C1-12 asphalt, No. c1-3 lease);Re2 is h, C1-6 tar, cyclo-c3-8, arilo (especially phenyl or nafos),Isopropene (especially pyridine, furan, Tianjin, pyridine, indolilo),4. Tetrahydropyridine, tetrahydrazine and other substances defined in memory; RE3 is h, C1-6 tar, C3-8 cyclopentadiene, arilo (especially phenyl or endorphin),heteroaryl (in particular pyridyl, thienyl, imidazolyl, indolyl) and others as defined herein; the groups mentioned can be linked under RE1 and RE2 to each other by a link; the groups mentioned under RE2 and RE3 can also be linked together through a link; RE2 is also CORE5 (RE5 is equal to OH, O-C1-6 alkyl, O-C1-3 alkyl-aryl),Conre6re7 (where R6 or R7 equals h, C1-6, rental c0-3),Nre6re7; E may also be D-Asp, D-Glu, D-Lys, d-orn, d-su, d-dab, d-dap, D-Arg; G is a set of LG = 2, 3, 4 or 5 formulas, in which a set of CH2 in the ring can be replaced by O, s, NH, nalquilo c1-3, Choh, CHO acquilo c1-3, C (c1-3 Baibai reservoir) 2, ch-3,CHF, CHCl, CF2, etc. described in the report; in addition, G is a formula group (7),QG is 0, 1, 2; RG is 0, 1, 2; Rg3 is h, C1-6 tar, C3-8 cyclopentadiene, arilo; rg4 is h, C1-6 tar, C3-8 cyclopentadiene, arilo (especially phenyl, nafilo);K is NH - (CH2) nk-qk, where NK = 0, 1, 2, 3; QK is equal to c2-6 tar, where up to two sets of CH2 can be replaced by O or s as described in the report, others are C2 as described in the report; l represents a group formula (8),RL1 is equivalent to h, oh, o-asphalt C1-6, O - (CH2) 0-3-phenyl, co-6, co2-asphalt C1-6, co2-rental c1-3 or its tautometer, stereoisomer, salt and its products with tolerable acid or pharmacological basis. A pharmaceutical component containing a compound as an active component, and a pharmaceutical component for which the compound is used for preparation, used as a thrombus inhibitor, anticoagulant, supplement inhibitor, and anti-inflammatory agent. One of the characteristics of the new compounds is the binding of polyurethane protein inhibitors, which also has the function of amidina or guanidinia,1. An excimer with two or more hydroxyl functions, wherein the tar of the excimer is derived from a sugar derivative. Several sugar units or units extracted from sugar can be combined at present. This principle of docking of sugar derivatives leads to oral active compounds.
机译:阿米替林或阿米地平的化合物,其通式为abdegkl,其中a为h,CH3,H-(ra1)ia,其中ra1等于基团的式(1),其中ra2为h,NH2, nh-coch3,F,nhcho; RA 3为h,CH 2 OH; RA4为h,CH3,COOH; IA = 1-20; JA = 0、1、2; Ka = 2、3; La = 0,1; Ma = 0、1、2;如果ra1准分子大于1,则可以相同或不同; B是该基团(2)的通式; A-B是该基团的通式(3)之一;或n-乙酰基-n-丙烯酸的自由基神经元酸,其各自通过炭疽功能结合; RB1相当于h,CH2OH,C1-4焦油; Rb2等于h,NH2,nh-coch3,F,nhcho; RB3等同于h,C1-4焦油,ch2-o-4,COOH,F,nh-coch3,CONH2; RB4相当于c1h,C14焦油,Ch2-o-焦油C1-4,COOH,CHO,在后一种情况下,可能形成分子内的胶体。 RB5等于h,C1-4焦油,ch2-o-4,COH; KB = 0,1; LB = 0,1; LB = 0、1、2、3(Lb1与0不同,其中a = RB1 = RB3 = h,MB = KB = 0,D是链接); MB = 0、1、2、3、4; Nb = 0、1、2、3; rb6等于C1-4焦油,苯基,苯乙基; BB7等于h,C1-4焦油,苯,苯乙基; D等于o-n(RD1)-rd2-rd3-rd4。如果RD1等于h,则C1-4租赁土地; RD2等于C1-4相连或租赁的土地; RD3等于基团(4)的式,LD = 1、2、3、4、5、6和rd5等于h,C1-4烃,CL; rd6等于h,CH3;在这种情况下,可以将额外的芳族或芳族环结合到上述RD3环系统中; RD4等于链,C1-4烃,Co,SO2,ch2-co; E是一组公式(5),其中,Ke = 0、1、2; E = 0,1,2;我= 0、1、2、3; ne = 0,1,2; PE = 0、1、2; RE1是h,C1-6沥青,环8,芳基(特别是苯基或naftil),亚同晶(特别是吡啶,丁二烯,吡啶,吲哚基)等。存储器中定义的其他RE1,此外,re4oco-ch2--(RE4等于h,C1-12号沥青,c1-3号地契); Re2是h,C1-6焦油,环c3- 8,芳基(特别是苯基或萘酚),异丙烯(特别是吡啶,呋喃,天津,吡啶,吲哚洛),4。四氢吡啶,四肼和其他记忆中定义的物质; RE 3是h,C 1-6焦油,C 3-8环戊二烯,芳基(特别是苯基或内啡肽),杂芳基(特别是吡啶基,噻吩基,咪唑基,吲哚基)和本文所定义的其他基团;所述组可以在RE1和RE2下通过链接彼此链接; RE2和RE3下提到的组也可以通过链接链接在一起; RE2也是CORE5(RE5等于OH,O-C1-6烷基,O-C1-3烷基-芳基),Conre6re7(其中R6或R7等于h,C1-6,租约c0-3),Nre6re7; E也可以是D-Asp,D-Glu,D-Lys,d-orn,d-su,d-dab,d-dap,D-Arg; G是一组LG = 2、3、4或5公式,其中环中的一组CH2可被O,s,NH,nalquilo c1-3,Choh,CHO acquilo c1-3,C( c1-3白柏水库)2,报告中所述的ch-3,CHF,CHCl,CF2等;另外,G为式组(7),QG为0、1、2; RG为0、1、2; Rg3为h,C1-6焦油,C3-8环戊二烯,芳基; rg4是h,C1-6焦油,C3-8环戊二烯,芳基(特别是苯基,萘菲洛); K是NH-(CH2)nk-qk,其中NK = 0、1、2、3; QK等于c2-6焦油,其中多达两套CH2可以如报告中所述用O或s取代,其他两组如报告中所述为C2; l代表基团通式(8),RL1等同于h,哦,o-沥青C1-6,O-(CH2)0-3-苯基,co-6,co2-沥青C1-6,co2-租金c1 -3或其互变计,立体异构体,盐及其产物具有可耐受的酸或药理基础。含有化合物作为活性成分的药物成分,以及用于制备该化合物的药物成分,被用作血栓抑制剂,抗凝剂,补充抑制剂和抗炎剂。新化合物的特征之一是聚氨酯蛋白抑制剂的结合,它也具有a胺或胍基的功能,1。具有两个或多个羟基官能团的准分子,其中该准分子的焦油衍生自糖衍生物。目前可以合并几个糖单位或从糖中提取的单位。糖衍生物对接的原理导致口服活性化合物。

著录项

  • 公开/公告号AR036326A1

    专利类型

  • 公开/公告日2004-09-01

    原文格式PDF

  • 申请/专利权人 ABBOTT GMBH & CO. KG;

    申请/专利号AR2001P104681

  • 发明设计人

    申请日2001-10-04

  • 分类号C07H15/00;C07H7/00;A61K31/7028;A61P7/02;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号